Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 10, 2022
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
[ Thu, Nov 10th 2022
] - WOPRAI
Wed, November 9, 2022
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
[ Wed, Nov 09th 2022
] - WOPRAI
Gil Blum Maintained (TSHA) at Strong Buy with Decreased Target to $16 on, Nov 9th, 2022
Gil Blum of Needham, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $18 to $16 on, Nov 9th, 2022.
Gil has made no other calls on TSHA in the last 4 months.
There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Gil
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $16 on, Tuesday, November 8th, 2022
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $5 on, Friday, August 12th, 2022
